US Patent 7582782 Organic compounds
Patent 7582782 was granted and assigned to Novartis on September, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Article (+98 characters)
Article
Patent abstract
Disclosed are δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amide compounds of formula (I)
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07582782 Organic compounds US Patent 7582782 Organic compounds
Infobox
Patent Number
0758278200
Patent Number
758278200
Edits on 23 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075827820
Date of Patent
September 1, 2009
0Patent Application Number
105794270
Date Filed
November 25, 2004
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075827820
Date of Patent
September 1, 2009
0Patent Application Number
105794270
Date Filed
November 25, 2004
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07582782 Organic compounds
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07582782
Date of patent
September 1, 2009
Patent application number
10579427
Date Filed
November 25, 2004
Patent primary examiner
Find more entities like US Patent 7582782 Organic compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
